Abstract
Benefit sharing involving human genetic resources is an unresolved topic. Some argue that participation in scientific research should always be altruistically motivated, which is how access to human genetic resources has historically been governed in affluent nations. However, uncritically transferring the altruism model to developing countries leads to the emergence of serious exploitation issues. This chapter illustrates the potential for exploitation and other associated ethical concerns through a discussion of three cases: The Icelandic deCODE biobank for genetic research; the sex workers from Nairobi, Kenya, whose samples are used for ongoing HIV/AIDS research; and the Indonesian government’s decision to withhold virus samples from the World Health Organization in order to achieve fairer benefit sharing. Public attention is captured more easily by global pandemics, but the case of the Nairobi sex workers illustrates that the exploitation issues raised on the international stage by the Indonesian government are not limited to virus sharing. A framework for equitable access to human genetic resources is urgently needed, but in order to ensure justice, this needs to be accompanied by sustained attention to benefit sharing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
For example, the UK Biobank, a research project which collects health, medical and lifestyle information from large numbers of people, together with blood, saliva and urine samples in order to track participants’ long term health, states in its information letter to potential participants, ‘Taking part is not intended to help you directly, but it should give future generations a much better chance of living their lives free of diseases that disable and kill.’ http://www.ukbiobank.ac.uk/docs/participantinviteletter.pdf.
- 2.
For a further discussion of the homogeneity of the Icelandic population, see Árnason (2004).
- 3.
Mannvernd means literally ‘human protection’. Although Mannvernd calls itself, in its full name, the ‘Association of Icelanders for Ethics in Science and Medicine’, it is specifically the ‘organized opposition to the Icelandic government’s Act on a Health Sector Database’, according to its website (http://www.mannvernd.is). Its members are primarily medical doctors, scientists and academics. Mannvernd and its individual members were highly active and visible during the parliamentary debates on the Health Sector Database Act in 1998 and, to a lesser extent, during the following three or four years, as the association encouraged people to opt out of the database.
- 4.
‘Samkomulag á milli heilbrigðis- og tryggingamálaráðherra og Íslenskrar erfðagreiningar ehf. í tengslum við útgáfu rekstrarleyfis til gerðar og starfrækslu gagnagrunns á heilbrgiðissviði’ [Agreement between the Minister of Health and Insurance and Íslensk erfðagreining (deCODE) in relation to a licence to operate a health sector database], signed 21 January 2000 by the Minister of Health, Ingibjörg Pálmadóttir, and Kári Stefánsson, CEO of deCODE genetics Inc. Available (in Icelandic only) at http://www.mbl.is/serefni/decode/ (see articles 4 and 6).
- 5.
It decided in the case of Gudmundsdóttir v. the State of Iceland (No. 151/2003), that the daughter of a deceased man could prevent his health information from being entered into the Health Sector Database. For a good analysis of the judgment, see Gertz (2004).
- 6.
Apparently deCODE only received US$74.3 million out of the expected US$200 million (see Sigurdsson 2003).
- 7.
For example: ‘In all cases, the prior, free and informed consent of the person concerned shall be obtained. If the latter is not in a position to consent, consent or authorization shall be obtained in the manner prescribed by law, guided by the person’s best interest’ (UNESCO 1997: article 5(b)).
- 8.
‘Benefits from advances in biology, genetics and medicine, concerning the human genome, shall be made available to all, with due regard for the dignity and human rights of each individual’ (UNESCO 1997: article 12(a)). ‘[D]eveloping countries [should] benefit from the achievements of scientific and technological research so that their use in favour of economic and social progress can be to the benefit of all’ (UNESCO 1997: article 19(a)(iii)).
- 9.
UNESCO (2005), article 15, specifies examples of sharing benefits of scientific research in general.
- 10.
For a general discussion on this issue, see Andanda (2005).
- 11.
For a detailed discussion, see Jóhannesson (1999).
- 12.
See Andanda (2009) for a discussion of the women’s vulnerability.
- 13.
Interview with University of Nairobi researcher, GenBenefit, April 2007.
- 14.
The interviews quoted in this chapter were conducted as part of the GenBenefit project. Clearance was granted by the University of the Witwatersrand’s Human Research Ethics Committee (Non-medical), Protocol Number 61110, and the Kenya Medical Research Institute’s National Ethical Review Committee, reference number KEMRI/RES/7/3/1.
- 15.
This phenomenon was first described by Plummer at an international AIDS conference in Berlin in 1993 (Altman 1993).
- 16.
The cohort of female sex workers was established by Elizabeth Ngugi and colleagues from the University of Nairobi and the University of Manitoba (see Jeffreys 2001).
- 17.
Interview with a University of Nairobi researcher, GenBenefit, April 2007.
- 18.
Founded in 1996, the International AIDS Vaccine Initiative (IAVI) is a global not-for-profit, public-private partnership, with a mission to ensure the development of preventive AIDS vaccines that are not only safe and effective, but also accessible to all people http://www.iavi.org/Pages/home.aspx.
- 19.
Phase I trials are the earliest human tests in the life of a new drug. They involve few people and check for safety, side effects and efficacy. This information is used to establish the dose which will be used in the next stage of testing. Phase II trials are carried out in larger groups of volunteers, to establish more about efficacy, dosage and side effects.
- 20.
- 21.
After initial exposure to any agent, it takes time for antibodies to develop. At some point after initial HIV infection, seroconversion occurs. (Usually this takes a few weeks to a few months.) This means there is now a detectable level of antibodies to HIV in the blood, and a person will test (sero)positive for HIV.
- 22.
For example: ‘This study adds IRF-1, a transcriptional immunoregulatory gene, to the list of genetic correlates of altered susceptibility to HIV-1. This is the first report suggesting that a viral transcriptional regulator might contribute to resistance to HIV-1’ (Ball et al. 2007: 1091).
- 23.
Issues have been raised concerning the difficulties of communicating adequate information for obtaining meaningful consent from potential participants, given the difficulties of translating complex concepts into languages that may not (yet) have the linguistic resources to communicate those. ‘[T]he moment you begin to talk about even translating into a language that the subject, the participant understands, you find that most words do not exist here … so there is a problem of the concepts’ (interview with Kenya Medical Research Institute (KEMRI) Ethics Committee member, GenBenefit, Nairobi, April 2007).
- 24.
Interview with an official at the Ministry of Health (MoH), Kenya, GenBenefit, April 2007.
- 25.
This was confirmed by a University of Nairobi researcher, as well as some of the Majengo participants. It is important to note that this has been a major factor in the women’s (continuing) involvement: ‘I expected treatment, free of charge. Every time I fall sick I come here for treatment and it’s free.’; ‘It is their treatment, they give us free medicine because of the nature of our work’ (GenBenefit interviews, Nairobi, April 2007).
- 26.
Details came to public attention through the media, where an alleged patent dispute between the Universities of Nairobi and Oxford was first discussed in 2000 (Turner 2000). It was reported that disagreements arose when University of Nairobi scientists protested that their partners at Oxford had patented the HIV vaccine development process without acknowledging them (Daily Nation 2001). This dispute was resolved after ‘intense’ negotiations (Turner 2000) which resulted in a new memorandum of understanding between the parties. The 30-page memorandum was in force from 1 October 2001 to 30 September 2004. Although it provides that the collaborators will be joint applicants for, and owners of, rights, titles and interests in inventions and/or patents arising from the research, and that research benefits will be shared equally between them, it does not mention how the researchers would compensate the Majengo women who provided so many of the resources leading to the vaccine development (AAVP 2002).
- 27.
Interviews with Majengo participants, GenBenefit, Nairobi, April 2007.
- 28.
Some of the sex workers have pointed out that benefit sharing via national governments would be complicated by the fact that some of them are migrants from Tanzania or Uganda. Additional questions around benefits for the families of deceased participants have also been raised by several parties (see GenBenefit 2009).
- 29.
Interview with KEMRI Ethics Committee member, GenBenefit, Nairobi, April 2007.
- 30.
See Footnote 27.
- 31.
Ibid.
- 32.
See Footnote 29.
- 33.
Ibid.
- 34.
‘Material transfer’ here refers to the transfer of materials or specimens to another party.
- 35.
- 36.
As of August 2010 there had been 139 deaths recorded in Indonesia out of a total 168 cases (http://www.who.int/csr/disease/avian_influenza/country/cases_table_2010_08_31/en/index.html).
- 37.
See Footnote 35.
- 38.
- 39.
- 40.
An SMTA is a legal contract that governs the transfer of materials – typically biological materials – between two parties. An SMTA specifies the rights and obligations of provider and recipient, binding both to certain terms and conditions of transfer.
- 41.
The IHR in their current version, which came into force on 15 June 2007, are legally binding on 194 countries.
References
AAVP (2002) The Kenya AIDS Vaccine Initiative: Challenges and achievements. Newsletter of the African AIDS Vaccine Programme, 2
Altman LK (1993) HIV immunity discussed at Berlin conference. New York Times, 9 June. http://www.nytimes.com/1993/06/09/world/hiv-immunity-discussed-at-berlin-conference.html
Andanda P (2004) A golden chance for medical ethics in Kenya. SciDev.Net, 15 June. http://www.scidev.net/en/opinions/a-golden-chance-for-medical-ethics-in-kenya.html
Andanda P (2005) Informed consent. Dev World Bioeth 5(1):14–29
Andanda P (2008) Human tissue related inventions: Ownership and intellectual property rights in international collaborative research in developing countries. J Med Ethics 34(3):171–179
Andanda P (2009) Vulnerability: Sex workers in Nairobi’s Majengo slum. Camb Q Healthc Ethics 18(2):138–146
Andanda P, Lucas JC (2007) Majengo HIV/AIDS research case. A report for GenBenefit. http://www.uclan.ac.uk/schools/school_of_health/research_projects/files/health_genbenefit_nairobi_case.pdf
Árnason G (2004) Interbreeding within the Icelandic population is high compared to that of mice or fruit-flies. In: Árnason G, Nordal S, Árnason V (eds) Blood and data: Ethical, legal and social aspects of human genetic databases. University of Iceland Press, Reykjavik, pp 29–35
Associated Press (1997) Nairobi prostitutes may hold key to AIDS vaccine. CNN, 25 Oct. http://www.cnn.com/HEALTH/9710/25/kenya.aids/index.html
Ball TB, Ji H, Kimani J, McLaren P, Marlin C, Hill AV, Plummer FA (2007) Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 21(9):1091–1101
Bandewar SVS, Kimani J, Lavery JV (2010) The origins of a research community in the Majengo observational cohort study, Nairobi, Kenya. BMC Public Health 10(630). http://www.biomedcentral.com/1471-2458/10/630
Berg K, Chadwick R (2001) Solidarity and equity: New ethical frameworks for genetic databases. Nat Rev Genet 2:318–321
Bergmann E (2010) How Iceland lost its soul. The Guardian, 13 April. http://www.guardian.co.uk/commentisfree/2010/apr/13/iceland-truth-committee-report
Bonn Guidelines (2002) The Bonn Guidelines on Access to Genetic Resources and the Fair and Equitable Sharing of the Benefits Arising out of their Utilization. Secretariat of the Convention on Biological Diversity, Quebec. http://www.cbd.int/doc/publications/cbd-bonn-gdls-en.pdf
Bower H (1998). Science: New hope. The Independent (London), 29 Nov. http://www.independent.co.uk/arts-entertainment/science-new-hope-1188207.html
Caplan AL, Curry DR (2007) Leveraging genetic resources or moral blackmail? Indonesia and avian flu virus sample sharing. Am J Bioeth 7(11):1–2
Carlin J (2003) Hope for Aids cure as prostitutes defy virus in the slums. The Observer, 23 Nov. http://www.guardian.co.uk/world/2003/nov/23/kenya.aids
Carmichael M (2010) The world’s most successful failure. Newsweek, 12 Feb (From the magazine issue dated 22 Feb 2010). http://www.newsweek.com/id/233494
CIOMS (2002) International ethical guidelines for biomedical research involving human subjects. Council for International Organizations of Medical Sciences. http://www.cioms.ch/publications/layout_guide2002.pdf
d’Adesky A, Jeffreys R (1999) The African connection: Sex workers provide clues for a vaccine. HIV+, 3 Mar. http://www.aegis.com/pubs/hivplus/issue3/ahead/african.html
Daily Nation (2001) Kenyan AIDS Scientists Win Recognition Battle. Daily Nation, 30 Aug. http://www.nationaudio.com/News/DailyNation/Supplements/horizon/06092001/story2.htm
Fang G, Kuiken C, Weiser B, Rowland-Jones S, Plummer F, Chen CH, Kaul R, Anzala AO, Bwayo J, Kimani J, Philpott SM, Kitchen C, Sinsheimer JS, Gaschen B, Lang D, Shi B, Kemal KS, Rostron T, Brunner C, Beddows S, Sattenau Q, Paxinos E, Oyugi J, Burger H (2004) Long-term survivors in Nairobi: Complete HIV-1 RNA sequences and immunogenetic associations. J Infect Dis 190(4):697–701
Fidler DP (2008) Influenza virus samples, international law, and global health diplomacy. Emerg Infect Dis 14(1):88–94
Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, MacDonald KS, Ngugi EN, Plummer FA (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. The Lancet 348(9038):1347–1351
Fowke KR, Dong T, Rowland-Jones SL, Oyugi J, Rutherford WJ, Kimani J, Krausa P, Bwayo J, Simonsen JN, Shearer GM, Plummer FA (1998) HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. AIDS Res Hum Retrovir 14(17):1521–1530
Fowke KR, Kaul R, Rosenthal KL, Oyugi J, Kimani J, Rutherford WJ, Nagelkerke NJ, Ball TB, Bwayo JJ, Simonsen JN, Shearer GM, Plummer FA (2000) HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunol Cell Biol 78(6):586–595
GenBenefit (2009) Consultative meeting proceedings, benefit sharing, pre- and post-study obligations in biomedical research. Fairview Hotel, Nairobi, Kenya, 27 May. http://www.uclan.ac.uk/schools/school_of_health/research_projects/files/health_genbenefit_final_nairobi_100909.pdf
Gertz R (2004) An analysis of the Icelandic supreme court judgement on the Health Sector Database Act. SCRIPT-ed 1(2):241–258
Grady C (2001) Money for research participation: Does it jeopardize informed consent? Am J Bioeth 1(2):40–44
Gulcher J, Stefánsson K (1998) Population genomics: Laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med 36(8):523–527
Hammond E (2009) Some intellectual property issues related to H5N1 viruses, research, and vaccines. Third World Network, Penang. http://www.twnside.org.sg/title2/avian.flu/papers/patent.paper.pdf
HUGO Ethics Committee (2000a) Editorial: Genetic benefit sharing. Science 290(5489):49
HUGO Ethics Committee (2000b) Statement on benefit-sharing, 9 April. http://www.eubios.info/BENSHARE.htm
Icelandic Parliament (1998) The Act on Health Sector Database, no. 139/1998. http://eng.velferdarraduneyti.is/acts-of-Parliament/nr/17659
IRIN (2010) Indonesia: Bird flu cases down but risk remains high. Integrated Regional Information Networks, 18 Jan. http://www.irinnews.org/report.aspx?reportid=87771
Jeffreys R (2001) Riddle women: Reports of progress toward understanding how some people appear to fight off HIV. The Body, November. http://www.thebody.com/content/art1571.html
Ji H, Ball TB, Kimani J, Plummer FA (2004) Novel interferon regulatory factor-1 polymorphisms in a Kenyan population revealed by complete gene sequencing. J Human Genet 49(10):528–535
Jóhannesson GT (1999) Kári í jötunmóð. Nýja bókafélagið, Reykjavík
Kaul R, Dong T, Plummer FA, Kimani J, Rostron T, Kiama P, Njagi E, Irungu E, Farah B, Oyugi J, Chakraborty R, MacDonald KS, Bwayo JJ, McMichael A, Rowland-Jones SL (2001a) CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Investig 107(10):1303–1310
Kaul R, Rowland-Jones SL, Kimani J, Dong T, Yang HB, Kiama P, Rostron T, Njagi E, Bwayo JJ, MacDonald KS, McMichael AJ, Plummer FA (2001b) Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Investig 107(3):341–349
Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T, Kiama P, Rutherford J, Njagi E, Mwangi F, Rostron T, Onyango J, Oyugi J, MacDonald KS, Bwayo JJ, Plummer FA (2001c) New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 79(1–2):3–13
Lavery JV, Bandewar SVS, Kimani J, Upshur, Ross EG, Plummer FA, Singer PA (2010) ‘Relief of oppression’: An organizing principle for researchers’ obligations to participants in observational studies in the developing world. BMC Public Health 10(384). http://www.biomedcentral.com/1471-2458/10/384
MacKenzie D (2007) Indonesia resumes sharing bird flu virus samples. New Scientist, 27 Mar. http://www.newscientist.com/article/dn11474-indonesia-resumes-sharing-bird-flu-virus-samples.html
Marchant GE (2005) Property rights and benefit-sharing for DNA donors? Jurimetrics 45:153–178
Minister for Environment and Natural Resources (2006) The Environmental Management and Co-ordination (Conservation of Biological Diversity and Resources, Access to Genetic Resources and Benefit Sharing) Regulations, 2006. Issued under Legal Notice No. 160. Minister for Environment and Natural Resources, Nairobi
Ministry of Health (2005) Kenya national guidelines for research and development of HIV/AIDS vaccines, March. Kenya Ministry of Health, Nairobi
Okwemba A (2000) A history of exploitation. Daily Nation, 15 July
Okwemba A (2004) AIDS vaccine fails crucial test. Daily Nation, 9 Feb. http://www.nationmedia.com/dailynation/printpage.asp?newsid=14807
Potts J (2002) At least give the natives glass beads: An examination of the bargain made between Iceland and deCODE Genetics with implications for global bioprospecting. Va J Law Technol 7(3). http://www.vjolt.net/archives.php?issue=13
Revill J (2008) Jakarta ends stand-off on bird flu vaccines. The Observer, 24 Feb. http://www.guardian.co.uk/world/2008/feb/24/indonesia.birdflu
Roche (1998) Roche and DeCode Genetics Inc. of Iceland collaborate in genetic disease research. Roche – Corporate Media News, 2 Feb. Roche, Basel, Switzerland
Rose H (2001) The commodification of bioinformation: The Icelandic Health Sector Database. Wellcome Trust, London
Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, Blanchard T, Ariyoshi K, Oyugi J, Ngugi E, Bwayo J, MacDonald KS, McMichael AJ, Plummer FA (1998a) Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Investig 102(9):1758–1765
Rowland-Jones S, Dong T, Krausa P, Sutton J, Newell H, Ariyoshi K, Gotch F, Sabally S, Corrah T, Kimani J, MacDonald K, Plummer F, Ndinya-Achola J, Whittle H, McMichael A (1998b) The role of cytotoxic T-cells in HIV infection. Dev Biol Stand 92:209–214
Schroeder D, Lasén Diáz C (2006) Sharing the benefits of genetic resources: from biodiversity to human genetics. Dev World Bioeth 6(3):135–143
Sedyaningsih ER, Isfandari S, Soendoro T, Supari SF (2008) Towards mutual trust, transparency and equity in virus sharing mechanism: The avian influenza case of Indonesia. Ann Acad Med Singap 37(6):482–488
Sheremeta L (2003) Population genetic studies: Is there an emerging legal obligation to share benefits? Health Law Rev 12(1):36–38
Sigurdsson S (2003) Decoding broken promises. Open Democracy, 6 Mar. http://www.opendemocracy.net/theme_9-genes/article_1024.jsp
Simm K (2007) Benefit sharing frameworks: Justifications for and against benefit sharing in human genetic research. A report for GenBenefit. http://www.uclan.ac.uk/schools/school_of_health/research_projects/files/health_genbenefit_simm.pdf
Snorrason E (1998) Free medications for Icelanders harm their health. Letter to the parliamentary committee on health, 11 Nov. http://www.mannvernd.is/frettir/22.11.1998_okeypis_lyf_ernir_snorrason.html
Turner M (2000) Universities’ rift over Aids vaccine defused. Financial Times, 23 Oct. http://www.aegis.com/news/ads/2000/AD001902.html
TWN (2010) WHO: Virus-Benefit Sharing Working Group set up, pandemic flu response to be reviewed. TWN Info Service on Health Issues, 27 Jan. Third World Network
TWN (2011a) Agreement on influenza virus sharing and benefit sharing is a step forward but has some shortcomings. TWN Info Service on Health Issues, 20 April. Third World Network. http://www.twnside.org.sg/title2/health.info/2011/health20110402.htm
TWN (2011b) ‘Milestone’ virus/benefit-sharing agreement with shortcomings. TWN Info Service on Health Issues, 25 April. Third World Network. http://www.twnside.org.sg/title2/health.info/2011/health20110404.htm
UNAIDS (2000) Ethical considerations in HIV preventive vaccine research. UNAIDS guidance document, May. Joint United Nations Programme on HIV/AIDS, Geneva. http://data.unaids.org/publications/IRC-pub01/JC072-EthicalCons_en.pdf
UNAIDS (2012) Global Report. Joint United Nations Programme on HIV/AIDS and WHO Library. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf
UNESCO (1997) Universal Declaration on the Human Genome and Human Rights. United Nations Educational, Scientific and Cultural Organization. http://www.un-documents.net/udhghr.htm
UNESCO (2005) Universal Declaration on Bioethics and Human Rights. Adopted by the General Conference of the United Nations Educational, Scientific and Cultural Organization, 33rd Session, 19 Oct. http://portal.unesco.org/en/ev.php-URL_ID=31058&URL_DO=DO_TOPIC&URL_SECTION=201.html
Vaiman V, Davídsson PÁ, Sigurjónsson TO (2010) Revising a concept of corruption as a result of the global economic crisis: The case of Iceland. In: Stachowicz Stanusch A (ed) Organizational immunity to corruption: Building theoretical and research foundations. Polish Academy of Science Commission Regional Departure, Katowice, pp 363–372
Wade R (2009) Iceland as Icarus. Challenge 52(3):5–33
Waldholz M (2004) AIDS vaccine disappoints in tests: Experimental grug failed to show robust response in human immune system. Wall Street J, 3 Sept. http://www.aegis.com/news/wsj/2004/WJ040901.html
WHO (2005a) Guidance for the timely sharing of influenza viruses/specimens with potential to cause human influenza pandemics, March. World Health Organization, Geneva
WHO (2005b) Revision of the International Health Regulations, 23 May. WHA58.3. World Health Organization
WHO (2007a) Avian and pandemic influenza: Developments, response and follow-up, and application of the International Health Regulations (2005): Best practice for sharing influenza viruses and sequence data. Report by the Secretariat. Provisional agenda item 4.4, Executive Board 120th Session. EB120/INF.DOC./3, 11 Jan. World Health Organization. http://www.who.int/gb/ebwha/pdf_files/EB120/b120_id3-en.pdf
WHO (2007b) Avian and Pandemic Influenza. Provisional agenda item 12.1, Sixtieth World Health Assembly. A60/INF.DOC./2, 22 Mar 2007. World Health Organization
WHO (2007c) The World Health Report 2007 – A safer future: Global public health security in the 21st century. World Health Organization, Geneva. http://www.who.int/whr/2007/07_overview_en.pdf
WHO (2007d) Pandemic influenza preparedness: Sharing of influenza viruses and access to vaccines and other benefits. Agenda item 12.1, Sixtieth World Health Assembly. WHA60.28, 23 May. World Health Organization
WHO (2008) What are the International Health Regulations? Online Q&A, 10 April. World Health Organization. http://www.who.int/features/qa/39/en/index.html
WHO (2009) Pandemic influenza preparedness: Sharing of influenza viruses and access to vaccines and other benefits. Agenda item 12.1, Sixty-Second World Health Assembly. WHA62.10, 22 May. World Health Organization
WHO (2010) Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits. Agenda item 11.1, Sixty-Third World Health Assembly. WHA63.1, 19 May. World Health Organization
WHO (2011a) Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits. PIP/OEWG/3/4. World Health Organization. http://www.who.int/entity/csr/disease/influenza/pip_framework_16_april_2011.pdf
WHO (2011b) H5N1 avian influenza: Timeline of major events, 14 July. World Health Organization. http://www.who.int/csr/disease/avian_influenza/ai_timeline/en/index.html
Wilke M (2011) A plea for coherence where there is incoherence: The Nagoya Protocol, WHO and WIPO. Fairness and Bio-Knowledge, the Nagoya Protocol, Workshop at the School of Law, University of Warwick, 17 June
Williams G, Schroeder D (2004) Human genetic banking: Altruism, benefit and consent. New Genet Soc 23(1):89–103
WIPO (2007) Working paper: Patent issues related to influenza viruses and their genes. World Intellectual Property Organization. http://www.who.int/csr/disease/avian_influenza/wipo_ipdoc/en/index.html
WMA (2008) Declaration of Helsinki: Ethical principles for medical research involving human subjects. Adopted by the 18th World Medical Association General Assembly, Helsinki, Finland, June 1964, latest revision by the 59th WMA General Assembly, Seoul, Korea, October. http://www.wma.net/en/30publications/10policies/b3/index.html
Wulandari F, Pathoni A (2007) Indonesia to resume sharing bird flu virus samples. Reuters, 27 Mar.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lucas, J.C. et al. (2013). Donating Human Samples: Who Benefits? Cases from Iceland, Kenya and Indonesia . In: Schroeder, D., Cook Lucas, J. (eds) Benefit Sharing. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6205-3_5
Download citation
DOI: https://doi.org/10.1007/978-94-007-6205-3_5
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6204-6
Online ISBN: 978-94-007-6205-3
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)